Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Today Sponge

This article was originally published in The Tan Sheet

Executive Summary

FDA's NDAC to discuss remarketing and labeling of the vaginal contraceptive July 12 at the Holiday Inn in Bethesda, Md. Allendale Pharmaceuticals, which acquired the brand from American Home Products in December 1998, submitted a supplemental NDA (18-683) for the nonoxynol-9 contraceptive. The product was discontinued by AHP in 1995 due to manufacturing quality control shortcomings. In an April 24 citizen petition, D.C.-based Associated Pharmacologists & Toxicologists asked FDA to ban OTC sale of the sponge (1"The Tan Sheet" May 8, p. 9). An inspection of Allendale's manufacturing facility slated for May 22 was postponed by the agency, the company says. The July 12 meeting will run from 1 p.m. to 5:30 p.m.; parties interested in speaking during the open portion must file written submissions by July 6

You may also be interested in...



Allendale Pharma Today Sponge Relaunch $3 Mil. PR/Ad Campaign Planned

The U.S. relaunch of the Today Sponge is on the horizon, with an FDA inspection of the manufacturing facility for the OTC nonoxynol-9 contraceptive slated for the week of May 22. The product's marketer, Allendale Pharmaceuticals, submitted a supplemental NDA Jan. 23.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS091270

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel